Cargando…

High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy

AIMS: We aimed to assess structural progression in arrhythmogenic cardiomyopathy (AC) patients and mutation-positive family members and its impact on arrhythmic outcome in a longitudinal cohort study. METHODS AND RESULTS: Structural progression was defined as the development of new Task Force imagin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chivulescu, Monica, Lie, Øyvind H, Popescu, Bogdan A, Skulstad, Helge, Edvardsen, Thor, Jurcut, Ruxandra O, Haugaa, Kristina H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Fasttrack Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138527/ https://www.ncbi.nlm.nih.gov/pubmed/31504415 http://dx.doi.org/10.1093/eurheartj/ehz570

Ejemplares similares

A novel clinical method for quantification of regional left ventricular pressure–strain loop area: a non-invasive index of myocardial work
por: Russell, Kristoffer, et al.
Publicado: (2012)

Sex differences in disease progression and arrhythmic risk in patients with arrhythmogenic cardiomyopathy
por: Rootwelt-Norberg, Christine, et al.
Publicado: (2021)

Number of pregnancies and subsequent phenotype in a cross-sectional cohort of women with arrhythmogenic cardiomyopathy
por: Castrini, Anna I, et al.
Publicado: (2019)

Left Ventricular Dysfunction in Arrhythmogenic Cardiomyopathy: Association With Exercise Exposure, Genetic Basis, and Prognosis
por: Lie, Øyvind H., et al.
Publicado: (2021)

Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy
por: Smedsrud, Marit Kristine, et al.
Publicado: (2022)

Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation
por: Hjortnaes, Jesper, et al.
Publicado: (2010)

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
por: Steg, Ph. Gabriel, et al.
Publicado: (2011)

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2009)

The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy
por: Gold, Michael R., et al.
Publicado: (2011)

Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy
por: Tardif, Jean-Claude, et al.
Publicado: (2011)

One year follow-up of the multi-centre European PARTNER transcatheter heart valve study
por: Lefèvre, Thierry, et al.
Publicado: (2011)

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation
por: Matsa, Elena, et al.
Publicado: (2011)

Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study
por: Tanaka, Hidekazu, et al.
Publicado: (2010)

Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity® catheter system and the EnligHTN™ multi-electrode renal denervation catheter
por: Templin, Christian, et al.
Publicado: (2013)

Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial
por: Worthley, Stephen G., et al.
Publicado: (2013)

Pregnancy and Progression of Cardiomyopathy in Women With LMNA Genotype‐Positive
por: Castrini, Anna I., et al.
Publicado: (2022)

Management of patients with Arrhythmogenic Right Ventricular Cardiomyopathy in the Nordic countries
por: Haugaa, Kristina H., et al.
Publicado: (2015)

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry
por: Steg, Ph Gabriel, et al.
Publicado: (2012)

Acute Myocarditis-Like Episode in a Curly-Haired Young Boy—Red Flags for Familial Arrhythmogenic Cardiomyopathy
por: Pătru, Alina Elena, et al.
Publicado: (2020)

Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members
por: Saberniak, Jørg, et al.
Publicado: (2014)

Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia
por: Saberniak, Jørg, et al.
Publicado: (2017)

Progression of cardiac disease in patients with lamin A/C mutations
por: Skjølsvik, Eystein T, et al.
Publicado: (2021)

Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)
por: Murray, Brittney, et al.
Publicado: (2018)

Impact of pregnancy and risk factors for ventricular arrhythmias in women with tetralogy of Fallot
por: Quattrone, Alessia, et al.
Publicado: (2021)

Long-term follow-up and sex differences in adults operated for tetralogy of Fallot
por: Quattrone, Alessia, et al.
Publicado: (2021)

The German Aortic Valve Registry (GARY): in-hospital outcome
por: Hamm, Christian W., et al.
Publicado: (2014)

Unique genetic background and outcome of non‐Caucasian Japanese probands with arrhythmogenic right ventricular dysplasia/cardiomyopathy
por: Wada, Yuko, et al.
Publicado: (2017)

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
por: James, Stefan, et al.
Publicado: (2010)

Effects of serelaxin in subgroups of patients with acute heart failure: results from RELAX-AHF
por: Metra, Marco, et al.
Publicado: (2013)

Electrical markers and arrhythmic risk associated with myocardial fibrosis in mitral valve prolapse
por: Chivulescu, Monica, et al.
Publicado: (2022)

A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
por: Bairey Merz, C. Noel, et al.
Publicado: (2016)

Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium(†)
por: Riegger, Julia, et al.
Publicado: (2016)

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
por: Haynes, Richard, et al.
Publicado: (2013)

Data on exercise and cardiac imaging in a patient cohort with hypertrophic cardiomyopathy
por: Dejgaard, Lars A., et al.
Publicado: (2017)

Cardiac desmosomal reserve: another piece of the exercise-induced arrhythmogenic cardiomyopathy puzzle?
por: Haugaa, Kristina H., et al.
Publicado: (2021)

Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction—a hospital registry-primary care linked cohort (MINAP–GPRD)
por: Boggon, Rachael, et al.
Publicado: (2011)

Variants in the 3′ untranslated region of the KCNQ1-encoded K(v)7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner
por: Amin, Ahmad S., et al.
Publicado: (2012)

Heterotopic transcatheter tricuspid valve implantation: first-in-man application of a novel approach to tricuspid regurgitation
por: Lauten, Alexander, et al.
Publicado: (2011)

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial
por: Pitt, Bertram, et al.
Publicado: (2011)

Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease
por: Goto, Shinya, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_irh83deolrvmtdj1optsr2abjq